Clinical · Molecular biology
Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma
This study evaluated the utility of RNA sequencing and immunohistochemistry (IHC) for detecting NTRK fusions in thyroid carcinoma, particularly those potentially missed by gene panel testing. Two patient groups were analyzed: advanced thyroid cancer cases undergoing panel testing and surgical papillary thyroid carcinoma cases screened by IHC. Results indicated that a gene panel test missed one SQSTM1-NTRK3 fusion, while pan-TRK IHC showed variable sensitivity depending on the fusion type. The study concludes that active screening for NTRK fusions is desirable, especially in patients without MAPK pathway abnormalities or with positive pan-TRK staining.